Organigram Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
For the six months, sales was CAD 113.7 million compared to CAD 113.78 million a year ago. Revenue was CAD 74.08 million compared to CAD 82.81 million a year ago. Net loss was CAD 42.83 million compared to CAD 2.16 million a year ago. Basic loss per share from continuing operations was CAD 0.497 compared to CAD 0.028 a year ago. Diluted loss per share from continuing operations was CAD 0.497 compared to CAD 0.028 a year ago.